FDA Withdraws Approval of Amneal’s Celecoxib Capsule ANDA at Manufacturer’s Request

Withdrawal of drug approval for Celecoxib capsules by Amneal Pharmaceuticals

When a situation lacks clear scriptural guidance on the specific action, the appropriate response is to acknowledge insufficient context for moral judgment.

The event concerns a regulatory and commercial decision with no documented conduct that can be evaluated against biblical moral teachings. No passage among the supplied candidates directly addresses the moral dimensions of withdrawing a drug application.

No supplied passage directly relates to the conduct of withdrawing a pharmaceutical approval; therefore, no verses are cited.

The factual summary provides only procedural information about the FDA and Amneal's request, without any indication of ethical wrongdoing or virtue.

Only the supplied verses may be used; none of them speak to corporate regulatory actions, so a moral classification cannot be determined from the available scriptural evidence.